Literature DB >> 8949253

Functional imaging, affective disorder and dementia.

G M Goodwin1.   

Abstract

Perfusion imaging has had modest success thus far in mood disorder. The most consistent findings in both primary major depression and in secondary depression have been reductions in inferior frontal cortex, adjacent cingulate cortex, temporal cortex and basal nuclei. They are compatible with a primary network for the integration of emotional experience in inferior frontal cortex, striatum and amygdala which is partially supported by the findings from relevant lesions and activation studies in normal controls. There are additional findings implicating dorso-lateral prefrontal and adjacent medial/limbic cortex in some patient groups. In elderly men particularly, reductions in prefrontal cortex appear to correlate with cognitive impairment. In dementia, perfusion imaging with single photon emission tomography (SPET) is becoming established as an important clinical tool ancillary to neuropsychological testing. Quantitation and statistical definitions of regional abnormality will be worthwhile innovations as camera systems become more technically advanced.

Entities:  

Mesh:

Year:  1996        PMID: 8949253     DOI: 10.1093/oxfordjournals.bmb.a011563

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  3 in total

1.  Behavioural disturbance and visual hallucinations in a 78 year old man.

Authors:  D W Schultz; G G Lennox; J W Ironside; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

Review 2.  Late-life depression with comorbid cognitive impairment and disability: nonpharmacological interventions.

Authors:  Victoria M Wilkins; Dimitris Kiosses; Lisa D Ravdin
Journal:  Clin Interv Aging       Date:  2010-11-15       Impact factor: 4.458

3.  Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET).

Authors:  Siroos Mirzaei; Peter Knoll; Horst Koehn; Thomas Bruecke
Journal:  BMC Nucl Med       Date:  2003-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.